Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
The University of Texas MD Anderson Cancer Center · Cleveland Clinic · +25 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
179
total citations
- FWCI
- 48.57
- Percentile
- 100%
- References
- 30
Citations per year
Authors
195Topics & keywords
Topics
Keywords
- Myelofibrosis
- Danazol
- Medicine
- Double blind
- Internal medicine
- Gastroenterology
- Placebo
- Pathology
No related works found for this paper.